Form 4: Chromocell Therapeutics CEO Francis Knuettel II Reports Gift of Shares
SEC Form 4 Filing
CEO Francis Knuettel II reports gifting 20,000 shares of Chromocell Therapeutics Corp stock.
Summary
- On June 28, 2024, Francis Knuettel II, CEO, President, CFO, Treasurer, and Secretary of Chromocell Therapeutics Corp, reported a transaction involving the company's common stock.
- Mr. Knuettel gifted 5,000 shares and then 15,000 shares of common stock.
- The price per share for both transactions was $0.
- Following these transactions, Mr. Knuettel directly owns 515,510 shares of Chromocell Therapeutics Corp.
- The transactions were reported on July 2, 2024.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a gift of shares. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of the stock gift transaction |
| 07/02/2024 | Date of Form 4 filing |
Keywords
Form 4, Chromocell Therapeutics, Francis Knuettel II, Stock Gift, Beneficial Ownership, CHRO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.